Cannabinoids and psychosis (Q36756388)

16 August 2017

1 reference

title

Cannabinoids and psychosis (English)

1 reference

16 August 2017

0 references

1 reference

Deepak Cyril D'Souza

1

1 reference

16 August 2017

1 January 2007

1 reference

International Review of Neurobiology

16 August 2017

1 reference

16 August 2017

78

1 reference

16 August 2017

289-326

1 reference

Causal inference: the case of hygiene and health

16 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis and schizophrenia: a longitudinal study of cases treated in Stockholm County

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

A clinical and metabolic study of acute intoxication with Cannabis sativa and its role in the model psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

CANNABIS AND SCHIZOPHRENIA A Longitudinal Study of Swedish Conscripts

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Comparative psychotomimetic effects of stereoisomers of amphetamine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis psychosis and acute schizophrenia. a case-control study from India

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

The experimental reproduction of amphetamine psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Forty-six cases of psychosis in cannabis abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cerebellar hypoactivity in frequent marijuana users.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis psychosis following bhang ingestion

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Studies on psycho-clinical aspects of long-term marihuana use in 124 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Psychotic reactions following cannabis use in East Indians.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis consumption and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Antiemetic effect of intramuscular levonantradol in patients receiving anticancer chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Symptom provocation studies in psychiatric disorders: scientific value, risks, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

The Psychotomimetic Effects of Intravenous Delta-9-Tetrahydrocannabinol in Healthy Individuals: Implications for Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Systematic search for major genes in schizophrenia: Methodological issues and results from chromosome 12

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Studies on [3H]CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Testing hypotheses about the relationship between cannabis use and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Oral Levonantradol in the Treatment of Chemotherapy‐Induced Emesis: Preliminary Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis use correlates with schizotypal personality traits in healthy students

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Chemical constituents of marijuana: the complex mixture of natural cannabinoids

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis use predicts future psychotic symptoms, and vice versa

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis dependence and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

A frequent polymorphism in the coding exon of the human cannabinoid receptor (CNR1) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

1 reference

7 January 2021

Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Nonacute (residual) neuropsychological effects of cannabis use: a qualitative analysis and systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Being stoned: a review of self-reported cannabis effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Dextroamphetamine. Evaluation of psychomimetic properties in man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Adverse effects of cannabis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Substance abuse and the onset of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Marihuana-Modified Mania

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Effects of acute smoked marijuana on complex cognitive performance

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Clinical Experience with Levonantradol Hydrochloride in the Prevention of Cancer Chemotherapy‐Induced Nausea and Vomiting

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Randomized crossover study of the antiemetic activity of levonantradol and metoclopramide in cancer patients receiving chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Comparative sequencing of the human CB1 cannabinoid receptor gene coding exon: no structural mutations in individuals exhibiting extreme responses to cannabis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

A retrospective study of symptom patterns of cannabis-induced psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

A comparison of LSD-25 with (?)-?9-trans-tetrahydrocannabinol (THC) and attempted cross tolerance between LSD and THC

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Effects of (--)delta-9-trans-tetrahydrocannabinol in man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Evaluation of intramuscular levonantradol and placebo in acute postoperative pain

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Psychological studies of marijuana and alcohol in man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabidiol interferes with the effects of Δ9-tetrahydrocannabinol in man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Effects of delta9-tetrahydrocannabinol and cannabinol in man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Effects of Marihuana on Adolescents and Young Adults

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Levonantradol for Chemotherapy‐Induced Emesis: Phase I—II Oral Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Schizophrenia and the cannabinoid receptor type 1 (CB1): association study using a single-base polymorphism in coding exon 1

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

The effects of tetrahydrocannabinol on the recognition of emotionally charged words: an analysis using event-related brain potentials.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Elevated endogenous cannabinoids in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Effects of synthetic delta9-tetrahydrocannabinol on binocular depth inversion of natural and artificial objects in man

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Different effects of nabilone and cannabidiol on binocular depth inversion in Man.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis abuse and the course of recent-onset schizophrenic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Divided attention performance in cannabis users and non-users following alcohol and cannabis separately and in combination

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis use in a large sample of acute psychiatric admissions.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis and acute psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol: the ongoing story of cannabis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Marihuana and Temporal Disintegration

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Marijuana and memory impairment: effect on free recall and recognition memory.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

The incidence of schizotypy among cannabis and alcohol users.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis psychoses in south Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis Use is Not Associated With the Development of Psychosis in an ‘Ultra’ High-Risk Group

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Variation in the THC content of illicitly imported Cannabis products--1984-1989.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Some features of Cannabis plants grown in the United Kingdom from seeds of known origin

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

The residual neuropsychological effects of cannabis: the current status of research.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

The residual cognitive effects of heavy marijuana use in college students.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Neuropsychological performance in long-term cannabis users

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

The acute effects of cannabinoids on memory in humans: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Long-term cannabis use: characteristics of users in an Australian rural area

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Psychosis and cannabis abuse in The Gambia. A case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis-associated psychosis with hypomanic features

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis is more than simply delta(9)-tetrahydrocannabinol

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Double-Blind Multiple-Dose Crossover Study of the Antiemetic Effect of Intramuscular Levonantradol Compared to Prochlorperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis use is associated with schizotypy and attentional disinhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Do cognitive impairments recover following cessation of cannabis use ?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Differential impairments of selective attention due to frequency and duration of cannabis use.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cognitive functioning of long-term heavy cannabis users seeking treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Dose ranging evaluation of the antiemetic efficacy and toxicity of intramuscular levonantradol in cancer subjects with chemotherapy-induced emesis

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Early adolescent cannabis exposure and positive and negative dimensions of psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Psychiatric effects of hashish.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

1 reference

7 January 2021

Cannabis Psychosis and Paranoid Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis and the PSE.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

A community survey of adverse effects of cannabis use.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis and psychosis. Is there epidemiological evidence for an association?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Constituents of Cannabis sativa L. XVII. A review of the natural constituents

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Substance misuse at presentation to an early psychosis program

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis use and psychosis: a longitudinal population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis use and age at onset of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabis use and dimensions of psychosis in a nonclinical population of female subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Clinical characteristics of adolescents later hospitalized for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Psychosis due to "skunk".

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Effects of cannabidiol in animal models predictive of antipsychotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Cannabidiol monotherapy for treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Do Plasma Concentrations of Δ9-Tetrahydrocannabinol Reflect the Degree of Intoxication?

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0074-7742%2806%2978010-2

7 January 2021

10.1016/S0074-7742(06)78010-2

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17349865